MovDisordV3, Main, Exploration, bibRecord, 003B81

Progressive supranuclear palsy syndrome induced by clebopride

Identifieur interne : 003B81 ( Main/Exploration ); précédent : 003B80; suivant : 003B82

Progressive supranuclear palsy syndrome induced by clebopride

Auteurs : Jaume Campdelacreu [Espagne] ; Hatice Kumru [Espagne] ; Eduard Tolosa [Espagne] ; Josep Valls-Solé [Espagne] ; Antoni Benabarre [Espagne]

Source :

Movement Disorders [ 0885-3185 ] ; 2004-04.

RBID : ISTEX:6678459182A68AB62636455DAE79B1C14A90A943

Descripteurs français

Pascal (Inist)
- Antagoniste dopamine, Clébopride, Récepteur dopaminergique, Système nerveux pathologie.

English descriptors

KwdEn :
- Antiemetics (adverse effects), Benzamides (adverse effects), Clebopride, Dopamine antagonist, Dopamine receptor, Female, Humans, Middle Aged, Nervous system diseases, Supranuclear Palsy, Progressive (chemically induced), Supranuclear Palsy, Progressive (diagnosis), clebopride, drug‐induced parkinsonism, progressive supranuclear palsy.
MESH :
- chemical , adverse effects : Antiemetics, Benzamides.
- chemically induced : Supranuclear Palsy, Progressive.
- diagnosis : Supranuclear Palsy, Progressive.
- Female, Humans, Middle Aged.

Abstract

We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP‐like syndrome attributable to an antidopaminergic drug.© 2003 Movement Disorder Society

Url:

https://api.istex.fr/document/6678459182A68AB62636455DAE79B1C14A90A943/fulltext/pdf

DOI: 10.1002/mds.10692

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progressive supranuclear palsy syndrome induced by clebopride</title>
<author><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
</author>
<author><name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
</author>
<author><name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
</author>
<author><name sortKey="Valls Ole, Josep" sort="Valls Ole, Josep" uniqKey="Valls Ole J" first="Josep" last="Valls-Solé">Josep Valls-Solé</name>
</author>
<author><name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6678459182A68AB62636455DAE79B1C14A90A943</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.10692</idno>
<idno type="url">https://api.istex.fr/document/6678459182A68AB62636455DAE79B1C14A90A943/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001C56</idno>
<idno type="wicri:Area/Istex/Curation">001C56</idno>
<idno type="wicri:Area/Istex/Checkpoint">002562</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Campdelacreu J:progressive:supranuclear:palsy</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15077251</idno>
<idno type="wicri:Area/PubMed/Corpus">003478</idno>
<idno type="wicri:Area/PubMed/Curation">003478</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003351</idno>
<idno type="wicri:Area/Ncbi/Merge">000E06</idno>
<idno type="wicri:Area/Ncbi/Curation">000E06</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E06</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Campdelacreu J:progressive:supranuclear:palsy</idno>
<idno type="wicri:Area/Main/Merge">005539</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0261660</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002203</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000B18</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002039</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Campdelacreu J:progressive:supranuclear:palsy</idno>
<idno type="wicri:Area/Main/Merge">005877</idno>
<idno type="wicri:Area/Main/Curation">003B81</idno>
<idno type="wicri:Area/Main/Exploration">003B81</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Progressive supranuclear palsy syndrome induced by clebopride</title>
<author><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Valls Ole, Josep" sort="Valls Ole, Josep" uniqKey="Valls Ole J" first="Josep" last="Valls-Solé">Josep Valls-Solé</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clínic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Psychiatry Service. Hospital Clínic Universitari, Barcelona</wicri:regionArea>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-04">2004-04</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="482">482</biblScope>
<biblScope unit="page" to="484">484</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6678459182A68AB62636455DAE79B1C14A90A943</idno>
<idno type="DOI">10.1002/mds.10692</idno>
<idno type="ArticleID">MDS10692</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiemetics (adverse effects)</term>
<term>Benzamides (adverse effects)</term>
<term>Clebopride</term>
<term>Dopamine antagonist</term>
<term>Dopamine receptor</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Supranuclear Palsy, Progressive (chemically induced)</term>
<term>Supranuclear Palsy, Progressive (diagnosis)</term>
<term>clebopride</term>
<term>drug‐induced parkinsonism</term>
<term>progressive supranuclear palsy</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiemetics</term>
<term>Benzamides</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antagoniste dopamine</term>
<term>Clébopride</term>
<term>Récepteur dopaminergique</term>
<term>Système nerveux pathologie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP‐like syndrome attributable to an antidopaminergic drug.© 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
</region>
<name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
<name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
<name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
<name sortKey="Valls Ole, Josep" sort="Valls Ole, Josep" uniqKey="Valls Ole J" first="Josep" last="Valls-Solé">Josep Valls-Solé</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B81 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B81 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6678459182A68AB62636455DAE79B1C14A90A943
   |texte=   Progressive supranuclear palsy syndrome induced by clebopride
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Progressive supranuclear palsy syndrome induced by clebopride

Progressive supranuclear palsy syndrome induced by clebopride

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.